(11C)NNC-112
Showing 1 - 25 of 5,187
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)
Recruiting
- Thymic Epithelial Tumor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita Trial in London (IMP Application KM-001, Physical Examination,
Recruiting
- Punctate Palmoplantar Keratoderma Type 1
- Pachyonychia Congenita
- IMP Application KM-001
- +14 more
-
London, Whitechapel Rd, United KingdomRoyal London Hospital-Clinical Research Facility-11D (11th Floor
Jul 23, 2023
Acetoacetate and Acetate Metabolism in Chronic Kidney
Not yet recruiting
- Kidney Failure, Chronic
- PET scan metabolic day
- (no location specified)
Jul 20, 2023
ABPA Trial in Scottsdale, Santa Monica, Tampa (Itraconazole Powder, Placebo)
Recruiting
- ABPA
- Itraconazole Powder
- Placebo
-
Scottsdale, Arizona
- +2 more
Feb 1, 2023
Phantom Limb Pain, Pain, Chronic Trial in Medellin (Epidural catheter, Continuous sciatic nerve block)
Not yet recruiting
- Phantom Limb Pain
- Pain, Chronic
- Epidural catheter
- Continuous sciatic nerve block
-
Medellin, ColombiaAntioquia´s University
Nov 2, 2022
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Inflammation in Alzheimer's Disease and Related Dementias Using
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2023
Lung in Pulmonary Artery Hypertension (PAH)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Healthy
- TSPO PET scan (11C-PBR28)
- (no location specified)
Feb 16, 2023
Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)
Completed
- Ketoses, Metabolic
- Observational heart and kidney on siemens TEP scan
-
Sherbrooke, Quebec, CanadaResearch Center on Aging
Jan 16, 2023
Behavior, Health Trial in New Haven (Radiotracer)
Recruiting
- Behavior, Health
-
New Haven, ConnecticutYale University PET Center
Jun 13, 2022
Diabetic Retinopathy Trial in Puerto Rico, United States (Aflibercept Injection)
Recruiting
- Diabetic Retinopathy
- Aflibercept Injection
-
Beverly Hills, California
- +13 more
Jan 6, 2022
Tobacco Smoking, Nicotine Dependence Trial in United States (Very Low Nicotine Content Cigarettes, Normal Nicotine Content
Completed
- Tobacco Smoking
- Nicotine Dependence
- Very Low Nicotine Content Cigarettes
- Normal Nicotine Content Cigarettes
-
San Francisco, California
- +5 more
Jan 17, 2023
Systemic Lupus Erythematosus, Rheumatoid Arthritis Trial in United States (PF-06835375, Placebo)
Completed
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- PF-06835375
- Placebo
-
Anniston, Alabama
- +17 more
Apr 6, 2022
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
Healthy Volunteers - Liver Diseases Trial in Watford (NNC0560-0004, Placebo (NNC0560-0004))
Recruiting
- Healthy Volunteers - Liver Diseases
- NNC0560-0004
- Placebo (NNC0560-0004)
-
Watford, Middlesex, United KingdomNovo Nordisk Investigational Site
Nov 14, 2023
Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- NNC0114-0006
- +2 more
-
La Jolla, California
- +107 more
Mar 10, 2021
Obesity, Overweight Trial in San Antonio (NNC0487-0111, Placebo (NNC0487-0111))
Recruiting
- Obesity
- Overweight
- NNC0487-0111
- Placebo (NNC0487-0111)
-
San Antonio, TexasNovo Nordisk Investigational Site
Sep 28, 2023
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
Not yet recruiting
- Huntington Disease
- [11C]UCB-J
- [18F]SynVest-1
-
Leuven, BelgiumUZ Leuven
Nov 2, 2022
Dopaminergic Transporter Density (DAT) in Obese Women
Recruiting
- Obesity
- SPECT TRODAT-1
-
Ribeirão Preto, São Paulo, BrazilClinical Hospital of Ribeirão Preto Medical School
Mar 23, 2021